Table V.

Reactivity of allogeneic serum to SEREX-defined Ags (detected by positive phage clones)

ClonesNo. of Positive Sera/No. of Serum Samples
HCCHBV-infected (unabsorbed)Head and neck cancer (absorbed)Healthy donors (unabsorbed)
UnabsorbedAbsorbed
HCA582 /550 /13a0 /250 /100 /20
HCA1121 /551 /13a0 /250 /100 /20
HCA1373 /550 /13a0 /250 /100 /20
HCA6611 /551 /13b0 /250 /100 /20
HCA5191 /550 /13a0 /250 /100 /20
HCA5871 /551 /13b0 /250 /100 /20
HCA5201 /550 /13a0 /250 /100 /20
HCA561 /550 /13a0 /250 /100 /20
HCA56A1 /550 /13a0 /250 /100 /20
HCA591 /550 /13a0 /250 /100 /20
HCA641 /550 /13a0 /250 /100 /20
HCA661 /550 /13a0 /250 /100 /20
HCA671 /550 /13a0 /250 /100 /20
HCA901 /550 /13a0 /250 /100 /20
HCA1271 /550 /13a0 /250 /100 /20
  • a The original positive samples were not included.

  • b The original positive sample was included.